Category: Latest News
-
Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss
Roivant Sciences (NASDAQ:ROIV) said its majority-owned subsidiary Immunovant will discontinue development of IMVT-1402, also known as imeroprubart, in cutaneous lupus erythematosus after a proof-of-concept study failed to meet its primary endpoint. The randomised, double-blind, placebo-controlled trial enrolled 57 adults with cutaneous lupus erythematosus. Its primary endpoint measured the percentage change from baseline in the Cutaneous…
-
Beneficient Seeks Resolution to Eliminate About $130 Million of Disputed Debt Linked to Former CEO
Beneficient (NASDAQ:BENF) said it is seeking an agreement with former Chief Executive Officer Brad Heppner that would eliminate approximately $130 million of disputed debt and restructure his remaining equity and contractual interests in the company. Heppner was convicted on May 7, 2026, of federal charges including securities fraud and wire fraud. According to Beneficient, evidence…
-
Immunovant Shares Fall 6% After IMVT-1402 Lupus Study Misses Primary Endpoint
Immunovant (NASDAQ:IMVT) shares fell 6% on Monday after the company reported that a proof-of-concept study evaluating IMVT-1402 in cutaneous lupus erythematosus did not meet its primary endpoint. The trial did not achieve statistical significance on its primary endpoint, which measured the percentage change from baseline in the Cutaneous Lupus Erythematosus Disease Area and Severity Index…
-
Best Buy and Amazon Expand Fire TV Partnership Into Connected TV Advertising
Best Buy (NYSE:BBY) and Amazon (NASDAQ:AMZN) have expanded their multiyear Fire TV partnership to include connected television advertising, extending an existing agreement covering Best Buy’s Insignia TVs. Under the agreement, Fire TV will remain the exclusive software experience across all Insignia televisions produced by Best Buy, with models ranging from 24 to 85 inches. The…
-
Psyence BioMed Agrees Up to $5 Million PsyLabs Investment and Forms Texas Ibogaine Unit
Psyence Biomedical Ltd. (NASDAQ:PBM) has agreed to invest up to $5 million in Psyence Labs Ltd. and enter into a reciprocal share exchange with the company valued at approximately $9 million on each side. Psyence BioMed has irrevocably committed to invest $2.4 million in PsyLabs through the acquisition of 936 ordinary shares at $2,564 per…
-
CGI and D-Wave Quantum Partner on Enterprise Quantum Computing Applications
CGI (NYSE:GIB) and D-Wave Quantum Inc. (NYSE:QBTS) have entered into a strategic partnership focused on developing enterprise applications for quantum computing across sectors including logistics, transportation and retail. The agreement expands on more than a year of collaboration between the companies, according to a joint announcement. Under the partnership, CGI will incorporate D-Wave’s quantum computing…
-
GE Vernova Signs Services Deal for Five Gas Turbines in Egypt
GE Vernova Inc. (NYSE:GEV) has signed a services agreement to provide Rotor Life Extension solutions for five 9F gas turbines operating at three power plants in Egypt. The agreement covers turbines at the Kureimat, Nubaria and Cairo North facilities, which have a combined generating capacity of approximately 1,250 megawatts. The counterparties are affiliates of the…
-
Roche’s Sefaxersen Meets Primary Endpoint in Phase III Kidney Disease Trial
Roche Holding AG (USOTC:RHHBY) said Wednesday that sefaxersen met the primary endpoint in a Phase III trial evaluating the treatment in patients with IgA nephropathy. The IMAGINATION study showed a statistically significant reduction in proteinuria compared with placebo at 37 weeks, according to the Swiss pharmaceutical company. Proteinuria, or excess protein in the urine, is…
-
Six Flags Shares Rise as Jana Partners Calls for Potential Sale
Six Flags Entertainment Corp. shares rose 1.1% in pre-market trading on Wednesday to $12.44 after activist investor Jana Partners called on the company’s board to consider a potential sale of the business. Jana disclosed its position and demands on Tuesday evening, prompting a rise in Six Flags shares during after-hours trading. The hedge fund holds…
-
IonQ Shares Rise 11.8% After Quantum Error Correction Decoder Test
IonQ (NYSE:IONQ) shares rose 11.8% in pre-market trading on Wednesday after the quantum computing company announced the development and testing of a real-time quantum error correction decoder designed to operate on a single standard CPU. The company announced the results after Tuesday’s market close, describing the system as the industry’s first end-to-end real-time quantum error…